Sentences with phrase «compare outcomes of patients»

The study divided data into two segments to compare outcomes of patients treated before and after 2002, when the Pediatric End - Stage Liver Disease system (PELD) was instituted.

«Our study is one of the first to directly compare outcomes of patients treated at the same hospital during a set period of time.

Not exact matches

Under PPACA, certain fees, known as Patient - Centered Outcomes Research Institute («PCORI») fees, have been established for funding medical research and comparing outcomes of various medical tecOutcomes Research Institute («PCORI») fees, have been established for funding medical research and comparing outcomes of various medical tecoutcomes of various medical techniques.

How do APRN (advance practice registered nurses) patient outcomes compare with outcomes of other providers?

For the purposes of this economic evaluation, the forms were initially used in a related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.

We compared outcomes after medical versus surgical management of biliary tract disease in pregnant patients.We reviewed the clinical course of patients with symptomatic cholelithiasis during pregnancy from 1992 to 2002 at two university hospitals.Seventy - six women with 78 pregnancies were admitted with biliary tract disease.

Data comparing the rates of VBAC, as well as maternal and neonatal outcomes, after TOLAC to those after planned repeat cesarean delivery can help guide obstetricians or other obstetric care providers and patients when deciding how to approach delivery in women with a prior cesarean delivery.

While the researchers did not directly compare survival rates and neurological outcomes with whether individual patients received bystander CPR or defibrillation, they did find increases in both over the duration of the study.

To date, no systematic review has compared the direct and indirect effects of these three different training modalities on the outcomes of blood sugar control and blood fats in patients with type 2 diabetes.

The field is also expanding into patient - centered outcomes research, so not just comparing drug A with a placebo, but drug A versus drug B.» In spite of the uncertainties, she says, «It's an exciting time because we have a lot to learn.»

In the new study, patients receiving angioplasty with the new stents had a 47 percent higher risk of one of the outcomes identified as a primary endpoint in the study: death, heart attack and subsequent procedure to clear blocked arteries, as compared to patients who received bypass.

«Although radiosurgery has been shown to be an effective post-surgical treatment for metastatic brain tumors, previous studies did not compare patient outcomes from a single hospital over the same period of time,» said N. Scott Litofsky, M.D., chief of the Division of Neurological Surgery at the MU School of Medicine and senior author of the study.

The researchers then compared the images with the patients» outcomes after five months of chemotherapy.

The researchers assigned risk categories to each of the operations performed in the data pool, including colorectal and liver resections, and then compared 30 - day postsurgical outcomes among patients within similar risk groups.

«The use of a ceramide - infused barrier significantly decreased cost and increased satisfaction with patient - reported outcomes compared to conventional skin barriers,» said Janice C. Colwell, MS, RN, CWOCN, FAAN, of University of Chicago Medicine, a principal author of the study report.

In devising their experiment, the researchers took advantage of ambulance company practices that essentially provided a randomized group of patients to study, making it possible to compare outcomes at different hospitals.

The study, Developing an Interventional Stroke Service: Improving Clinical Outcomes and Reducing Cost and Delivering Great Cost Savings Benefits to Health Economy, conducted at the University Hospital of North Midlands, Stoke - on - Trent, U.K., found that mechanical thrombectomy (the use of a device to retrieve a clot from the vessel) in the treatment of stroke reduced the average stroke patient's hospital stay to 14 days when compared to previously recorded 90 days.

The results also indicate that older patients in any age group had higher incidence of all outcomes (nonfatal complications and death) if they had diabetes for a longer, compared with shorter, duration of time.

«By reducing bleeding with comparable rates of MACCE and stent thrombosis, bivalirudin significantly improved overall 30 - day and one year outcomes, compared with both heparin alone and heparin plus tirofiban in patients with AMI undergoing primary PCI,» said Gregg W. Stone, MD, the study's senior author.

Averaged over a four - year follow - up period, operatively treated patients at least 80 years of age, had significantly greater improvement in all primary and secondary outcome measures compared with patients at least 80 years of age who received nonsurgical treatment.

Comparing Options for Management: Patient - Centered Outcomes for Uterine Fibroids (COMPARE - UF) is a voluntary registry of 10,000 women with uterine fibroids funded by the Patient - Centered Outcomes Research Institute (PCORI) and the Agency for Healthcare Research and Quality (AHRQ).

The researchers next will turn to analyzing the presence of myoferlin in samples from numerous human tumor types available in an Ohio State tissue bank, which will allow them to compare protein levels in tumors to clinical outcomes for the patients who provided the samples.

In the study, researchers from Kansas City VA Medical Centre in Kansas City, USA, examined the effect of TRT on cardiovascular outcomes by comparing incidents of heart attack, stroke, and all - cause mortality among different sub-populations of treated and untreated patients.

The current study analysed outcomes in the subgroup of patients with EGFR expressing tumours compared to those with no EGFRs.

The odds of a good stroke outcome were 75 % greater for patients given alteplase within 3 hours of initial stroke symptoms, compared with those who did not receive the drug; for those given the drug between 3 and 4 · 5 hours post-stroke there was a 26 % increased chance of a good outcome; while for those with a delay of more than 4 · 5 hours in receiving treatment, there was just a 15 %, not statistically significant, increase in the chance of a good recovery.

A phase 2 trial showed a reduction in the combined outcome of death or myocardial infarction (heart attack) in patients treated with otamixaban compared with unfractionated heparin (UFH) plus eptifibatide (an antiplatelet drug) and showed similar bleeding rates with otamixaban at midrange doses.

This data was then compared with patients» outcomes, including heart attack or the occurrence of major adverse cardiac events within 30 days.

The results of the Endovascular Therapy Following Imaging Evaluation for the Ischemic Stroke (DEFUSE 3) trial, presented at the International Stroke Conference 2018 in Los Angeles and published on Jan. 24 in the New England Journal of Medicine, demonstrated that physically removing brain clots up to 16 hours after symptom onset in selected patients led to improved outcomes compared to standard medical therapy.

«The first task is to compare the medical outcomes of patients when alarms sound within their area vs. when alarms are intentionally muted and sent to staff via pagers or cell phones,» she said.

Looking at the components of the primary outcome separately, only hospitalizations, specifically for heart failure, had a significantly lower incidence for those taking spironolactone compared to placebo, with 206 patients (12.0 percent) in the spironolactone group undergoing hospitalization versus 245 patients (14.2 percent) in the placebo group.

The researchers compared hemoglobin levels of these patients and their outcomes within one year of surgery.

Christiani would like to see an experiment that compares the survival of patients administered large doses of the vitamin during treatment and follow - up periods against the outcomes of people who rely on diet and conventional therapy alone.

Michelle Hladunewich, MD (Sunnybrook Health Sciences Centre, in Toronto) and her colleagues assessed the effects of such intensive dialysis on pregnancy outcomes by comparing patients from Toronto with that from the United States.

Patients who underwent open - heart surgery in the afternoon experienced better health outcomes compared to those who got operated on in the morning, study authors found after six years of observing nearly 600 patients who underwent heart valve replPatients who underwent open - heart surgery in the afternoon experienced better health outcomes compared to those who got operated on in the morning, study authors found after six years of observing nearly 600 patients who underwent heart valve replpatients who underwent heart valve replacement.

Favourable outcomes, ranging from moderate disability to good recovery, occurred in only a quarter of the patients in the hypothermia group compared with more than a third of patients in the control group.

PD - L1 expression intensity was scored on a scale of 0 to 3 — with» 0» signifying no expression,» 1» signifying weak expression,» 2» moderate, and» 3» strong — and then compared the score with survival data and outcomes from those patients.

«This study allowed us to look more closely at the long - term outcomes of patients in whom the localized cancer in the prostate was successfully eradicated and compare them to patients whose disease persisted within the prostate following treatment,» adds Dr. Krauss.

As to the reason why certain racial and ethnic minorities have poorer rates of treatment for cardiovascular disease and generally have poorer cardiovascular health outcomes compared to white patients, Dr. Ladapo concludes that no one has really explored whether there could be disparities in cardiac stress testing, which is a mainstay of diagnosing patients with heart disease in this country.

Both one and two year rates of adverse outcomes compared favorably with historical performance criteria established among medically managed patients with aortic stenosis.

«Exploratory analyses of several secondary outcomes indicated that the sedation protocol was associated with a difference in patients» sedation experience; patients in the intervention group were able to be safely managed in a more awake and calm state while intubated, receiving fewer days of opioid exposure and fewer sedative classes without an increase in inadequate pain or sedation management or clinically significant iatrogenic [consequence of treatment] withdrawal compared with patients receiving usual care, but they experienced more days with reported pain and agitation, suggesting a complex relationship among wakefulness, pain, and agitation,» the authors write.

Sixty - three percent of patients who did not receive epinephrine achieved this outcome, compared to only 19 percent of those who received epinephrine.

«Triple - negative breast cancers tend to be more aggressive compared to other types of breast cancers, and being able to predict response to therapy could greatly impact treatment decisions and patient outcomes,» says study author Shaveta Vinayak, MD, oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine.

Using data from two academic institutions, Derosa and colleagues compared outcomes in patients with advanced RCC or NSCLC who had received antibiotics within 30 days of beginning immunotherapy against outcomes in those who did not.

[79] A total of 86 patients with advanced mucosal melanoma were included in the nivolumab monotherapy analysis, and 35 patients with mucosal melanoma were included in the combination therapy analysis; in addition, outcomes in these patients were compared with outcomes in patients with cutaneous melanoma who were treated in these clinical studies.

Non-controlled, observational study comparing outcomes of non-study patients to those participating in a controlled clinical trial.

The prognosis of each group of patients was examined by Kaplan - Meier survival estimators, and the survival outcomes of the two groups were compared by log - rank tests.

The researchers compared patient outcomes in surgeries which did not experience a handover of anesthesia care with those where the primary anesthesiologist transferred care to a colleague and did not return to the operating room.

The inpatient setting, compared with the outpatient setting, offers a unique advantage when studying patient outcomes between male and female physicians: within a given hospital, there is plausibly less selection of the physician by the patient or of the patient by the physician.

In a substudy, review outcomes were also compared across different types of clinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified human tissue.

The use of anti-CD19 chimeric antigen receptor T cells induced a nearly sixfold higher rate of complete response compared with historical outcomes in patients with refractory, aggressive non-Hodgkin lymphoma.